$ Value
$14K
Shares
11,000
Price
$1
Filed
Jun 2
Insider
Name
Soffer Rock
Title
—
CIK
0001845308
Roles
Transaction Details
Transaction Date
2025-05-30
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
209,034
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.29 to $1.305, inclusive. The reporting person undertakes to provide to Longeveron Inc., any security holder of Longeveron Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.24 to $1.255, inclusive. The reporting person undertakes to provide to Longeveron Inc., any security holder of Longeveron Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. | Includes RSUs subject to future vesting. | Share amounts include 41,010 shares of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.
Filing Info
Soffer Rock's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-07-15 | LGVN | A | $0 |
| 2025-05-30 | LGVN | ▼ | $14K |
| 2025-05-29 | LGVN | ▼ | $13K |
| 2025-05-22 | LGVN | ▼ | $3K |
Other Insiders at LGVN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Willard Stephen H
Chief Executive Officer
|
— | — | 2026-04-01 |
|
Lehr Paul T
General Counsel, Secretary
|
— | — | 2026-04-01 |
|
Agafonova Nataliya
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Locklear Lisa
Chief Financial Officer
|
— | — | 2026-04-01 |
|
Blass Devin
CTO & SVP of CMC
|
— | — | 2026-04-01 |